Navigation Links
BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
Date:3/17/2009

uth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts, including but not limited to statements regarding the Company's competitive advantages, the impact of changes in China's healthcare industry on the Company's growth, the Company's expected financial performance in 2009 and the Company's expectations for each of its business units in 2009. These statements are subject to uncertainties and risks including, but not limited to, operating performance, general financial, economic, and political conditions affecting the biotechnology and pharmaceutical industries and the Chinese pharmaceutical market, the ability to timely manufacture and distribute the Company's products and other risks contained in reports filed by the Company with the Securities and Exchange Commission. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.



                    BMP Sunstone Corporation and Subsidiaries
             Non GAAP Condensed Consolidated Statements of Operation
                ($ amounts, except per share amounts in thousands)

                                           For the Three      For the Twelve
                                            months ended       months ended
                                            December 31,       December 31,
                                           2008     2007      2008      2007

    Revenues:
     Third parties       
'/>"/>
SOURCE  BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 

Related biology technology :

1. BMP Sunstone to Present at UBS Global Healthcare Services Conference
2. BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009
3. BMP Sunstone Receives High Tech Status
4. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
5. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
6. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
7. BMP Sunstone Reports Third Quarter 2008 Financial Results
8. BMP Sunstone Announces Participation in November Investor Conferences
9. BMP Sunstone Announces Participation in September Investor Conference
10. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
11. BMP Sunstone Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 22% for fiscal 2009; on track for positive ... 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a ... today reported financial results for fourth quarter and ... 30, 2009, Microbix reported revenues of $6.08 million, ... 2008. For fourth-quarter 2009, the Company saw revenues ...
(Date:12/16/2009)... Trial conducted pursuant to Special Protocol Assessment ... QUEBEC CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna ... AEZ) (the "Company"), a global biopharmaceutical company ... announced the initiation, by its partner Keryx ... Phase 3 registration clinical trial for perifosine ...
(Date:12/16/2009)... HAMBURG, Germany, December 16 Eppendorf ... Verigene(R) and Verigene(R) SP systems for,infringement of ... titled "Method for the,identification and/or the quantification ... any and all imports of the respective ... Customs authorities are required to confiscate any,violating ...
(Date:12/16/2009)... Separations Society will hold its 23rd Annual Technical Conference & Exhibition ... Antonio, Texas. To further impact the separation society and reach out ... announce that the 2010 AFS Annual Technical Conference will be co-located ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- The American Filtration ...
Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4
... a global,provider of pharmaceutical competitive intelligence and market ... insight for pharma,and biotech companies with a stake ... Biogen/Elan,s Tysabri has been under scrutiny due to ... potentially fatal brain disease,associated with use of the ...
... Lead Arpida,s North-American Commercial Operations, REINACH, Switzerland, August ... results for the six months ending,30 June 2008., ... pipeline progress:, - Regulatory filings for intravenous iclaprim ... - Enrolment in Phase II "intravenous-to-oral" switch trial with ...
... at the University of Pennsylvania have theorized a way ... bound across chains of tiny metal particles to well ... shape. Application of this theory would use nanosized ... optical devices, which would operate at higher frequencies than ...
Other Biology Technology:Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri 2Arpida Reports Interim Results for Six Months to 30 June 2008 2University of Pennsylvania scientists move optical computing closer to reality 2University of Pennsylvania scientists move optical computing closer to reality 3
(Date:12/14/2009)... part of an international team that has used DNA ... the history of North America,s woolly mammoths and ancient ... and Atmospheric Sciences professor Duane Froese and his colleagues ... of bones and teeth. That analysis concluded that more ... (the ,megafauna,) disappeared about 13,000 years ago. , ...
(Date:12/14/2009)... can be transmitted by sneezing, touching, or for ... a habit that may have driven the dinosaurs to ... Jacqueline Upcroft, a member of f1000 Biology, highlights the ... in PLoS One. This led them to deduce that ... jaw bones seen in many tyrannosaurid fossils. , The ...
(Date:12/14/2009)... from the Astrobiology Centre (INTA-CSIC) has shown that hydrogen ... formation of the most basic biological molecules can be ... carry out this study, published in the journal ... conditions of the early Earth. , "We have shown ... it produces hydrogen cyanide, a substance that could have ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Pacific Biometrics Completes 244 Million Debt Financing 10024 1Pacific Biometrics Completes 244 Million Debt Financing 10024 2Pacific Biometrics Completes 244 Million Debt Financing 10024 3Pacific Biometrics Completes 244 Million Debt Financing 10024 4Pacific Biometrics Completes 244 Million Debt Financing 10024 5Reportlinker Adds World Dynamic Signature Verification Market Report 10021 1Reportlinker Adds World Dynamic Signature Verification Market Report 10021 2Reportlinker Adds World Dynamic Signature Verification Market Report 10021 3Reportlinker Adds World Dynamic Signature Verification Market Report 10021 4Reportlinker Adds World Dynamic Signature Verification Market Report 10021 5Reportlinker Adds World Dynamic Signature Verification Market Report 10021 6Reportlinker Adds World Dynamic Signature Verification Market Report 10021 7Reportlinker Adds World Dynamic Signature Verification Market Report 10021 8Reportlinker Adds World Dynamic Signature Verification Market Report 10021 9BIO key Retains Former Senior FBI Official as Strategic Advisor and Consultant 10018 1BIO key Retains Former Senior FBI Official as Strategic Advisor and Consultant 10018 2BIO key Retains Former Senior FBI Official as Strategic Advisor and Consultant 10018 3BIO key Retains Former Senior FBI Official as Strategic Advisor and Consultant 10018 4
... drug addiction, neurodegenerative diseases, epilepsy, immune system defects, ... fruit fly (Drosophila melanogaster) is providing an excellent ... others. More than 5,000 researchers worldwide are currently ... will have beneficial effects for health; Spain is ...
... finasteride, taken by millions of balding men, artificially lowers ... standard screening test for prostate cancer, a multicenter study ... ranging in age from 40 to 60 years old, ... Lancet and is scheduled to be published after Jan. ...
... Rutgers researchers have discovered that the Chlamydia bacterium, which ... heritage with plants. That shared evolutionary heritage, which is ... prime target for development of an effective cure for ... bacterium and plants had been proposed by others," said ...
Other Biology News:A valuable fly for research into disease 2Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds 2Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia 2Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia 3
...
...
Use as the souce of CETP enzyme for screening CETP inhibitors. Use in conjunction with the CETP activity assay kit (K601-100)....
... The Zero Background Cloning Kit includes the ... in E. coli. The pZErO-1 vector utilizes ... small size of the Zeocin resistance gene ... ligation and transformation efficiencies. The kit contains ...
Biology Products: